Enovis Past Earnings Performance

Past criteria checks 0/6

Enovis's earnings have been declining at an average annual rate of -55.6%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been declining at an average rate of 14.7% per year.

Key information

-55.6%

Earnings growth rate

-56.3%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate-14.7%
Return on equity-1.6%
Net Margin-3.2%
Next Earnings Update02 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Enovis makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:C520 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231,707-5479275
29 Sep 231,661-11277172
30 Jun 231,627-15975267
31 Mar 231,594-2373064
31 Dec 221,563-3971261
30 Sep 221,553170161
01 Jul 221,5305462658
01 Apr 221,491-10963954
31 Dec 211,426-10364249
01 Oct 211,855-48524102
02 Jul 212,301-1870190
02 Apr 212,5652175960
31 Dec 201,121-7551134
02 Oct 203,1315388662
03 Jul 203,1723989862
03 Apr 203,4604295280
31 Dec 193,327887362
27 Sep 193,0141084334
28 Jun 192,6922168234
29 Mar 192,3446651334
31 Dec 182,19310846334
28 Sep 182,492-11549243
29 Jun 182,813-8454443
30 Mar 183,100-9258543
31 Dec 171,9372842533
29 Sep 173,23915461239
30 Jun 173,16114759839
31 Mar 173,04315156639
31 Dec 163,18613860639
30 Sep 163,43514464342
01 Jul 163,63712671242
01 Apr 163,93313879042
31 Dec 153,43415865738
25 Sep 154,11220481443
26 Jun 154,30725982243
27 Mar 154,48139786043
31 Dec 144,62437087843
26 Sep 144,58932288427
27 Jun 144,44029984727
28 Mar 144,31416080827
31 Dec 134,20715479127
27 Sep 134,06313785619
28 Jun 134,0039186519

Quality Earnings: C520 is currently unprofitable.

Growing Profit Margin: C520 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: C520 is unprofitable, and losses have increased over the past 5 years at a rate of 55.6% per year.

Accelerating Growth: Unable to compare C520's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: C520 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).


Return on Equity

High ROE: C520 has a negative Return on Equity (-1.57%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.